Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway

Ke Lin(Sir Run Run Shaw Hospital), Jinquan Wang(Institute of Chemical and Engineering Sciences)
Frontiers in Oncology
February 18, 2020
Cited by 38


Related Papers